2015 ASCO GU General Views

Orlando, FL - ISC 2015 - Emmanuel S. Antonarakis, MD discusses ABSTRACT 138: AR Splice Variant 7 (AR-V7) And Response To Taxanes In Men With Metastatic Castration-Resistant Prostate Cancer (MCRPC) during General Session 2: Evolving Role Of Multimodality Treatment In Low-Volume Hormone-Sensitive Metastatic Disease at the 2015 Genitourinary Cancers Symposium here today, Thursday February 26, 2015. The conference is the premier meeting on the science and treatment of Genitourinary Cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 1,800 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2015

15GU00704Emmanuel S. AntonarakisMD discusses ABSTRACT 138 AR Splice Variant 7 ARV7 And Respo